05.01.17
GERMANY: Evonik is acquiring Dr. Straetmans GmbH of Hamburg, Germany, a maker of alternative preservatives for the cosmetic industry. The move allows Evonik to complement the broad specialties portfolio of its cosmetics business and to further consolidate its position as a leading global partner for the cosmetics industry. The transaction, subject to approval by the relevant antitrust authorities, is expected to be finalized in the first half of 2017. The contracting parties have agreed not to disclose the purchase price amount.
“Dr. Straetmans is a perfect match, both strategically and culturally, for us. We intend to develop the company’s business globally beyond its existing markets in Europe and the US,” said Hans-Josef Ritzert, member of the management board of Evonik Nutrition & Care GmbH.
Dr. Straetmans, which employs more than 60 people, will continue to operate as a legal entity. The company’s Hamburg site will become Evonik’s global competence center for preservative solutions.
“Our aim is to offer cosmetics manufacturers new solutions enabling them to distinguish themselves from the competition,” noted Tammo Boinowitz, who heads the personal care business line at Evonik. “In the future, we will be able to offer complete formulation systems, including preservation. In doing so, we make an important contribution to optimizing our customers’ development work.”
Established in 1984, Dr. Straetmans was a pioneer of alternative preservative systems. The difference between these and conventional preservatives is, among others, that the functions they perform in the final product go beyond preservation, for example, by acting as an additional moisturizer. At the same time, it is becoming more important for cosmetics manufacturers to sustainably formulate their products. In doing so, customer demands and regulatory requirements must be taken into account. The use of alternative preservative systems is complex, however.
“The reason for this is that we’re introducing larger amounts of surface active ingredients into the formulation. Our competencies in areas such as application and formulation allow us to maintain a stable emulsion,” explained Jan Jänichen, managing director, Dr. Straetmans.
Wilfried Petersen, also managing director of Dr. Straetmans, adds: “In combination with Evonik’s emulsifier expertise, we can provide our customers with even better support for developing formulations.”
In addition to alternative preservatives, Dr. Straetmans offers selected conventional preservatives. The decades-long experience of both sides and the comprehensive product range mean that the companies can, in the future, offer customers formulation concepts for sustainable use.
“Dr. Straetmans is a perfect match, both strategically and culturally, for us. We intend to develop the company’s business globally beyond its existing markets in Europe and the US,” said Hans-Josef Ritzert, member of the management board of Evonik Nutrition & Care GmbH.
Dr. Straetmans, which employs more than 60 people, will continue to operate as a legal entity. The company’s Hamburg site will become Evonik’s global competence center for preservative solutions.
“Our aim is to offer cosmetics manufacturers new solutions enabling them to distinguish themselves from the competition,” noted Tammo Boinowitz, who heads the personal care business line at Evonik. “In the future, we will be able to offer complete formulation systems, including preservation. In doing so, we make an important contribution to optimizing our customers’ development work.”
Established in 1984, Dr. Straetmans was a pioneer of alternative preservative systems. The difference between these and conventional preservatives is, among others, that the functions they perform in the final product go beyond preservation, for example, by acting as an additional moisturizer. At the same time, it is becoming more important for cosmetics manufacturers to sustainably formulate their products. In doing so, customer demands and regulatory requirements must be taken into account. The use of alternative preservative systems is complex, however.
“The reason for this is that we’re introducing larger amounts of surface active ingredients into the formulation. Our competencies in areas such as application and formulation allow us to maintain a stable emulsion,” explained Jan Jänichen, managing director, Dr. Straetmans.
Wilfried Petersen, also managing director of Dr. Straetmans, adds: “In combination with Evonik’s emulsifier expertise, we can provide our customers with even better support for developing formulations.”
In addition to alternative preservatives, Dr. Straetmans offers selected conventional preservatives. The decades-long experience of both sides and the comprehensive product range mean that the companies can, in the future, offer customers formulation concepts for sustainable use.
